Barclays PLC
3 April 2002
3 April 2002
Notification of directors' interests: Companies Act 1985 s.329
1. The trustee of the Barclays Qualifying Employee Share Ownership Trust
(the 'Quest') notified the Company on 2 April 2002 that it subscribed for a
total of 14,183 Barclays PLC ordinary shares on 2 April 2002 at a price of 2183p
per share. Following this transaction, the trustee of the Quest held a total of
14,183 Barclays PLC ordinary shares in which the following directors of Barclays
PLC had an interest as potential beneficiaries: Sir Peter Middleton, Mr M W
Barrett, Mr C J Lendrum, Mr J M Stewart and Mr J S Varley. (The Quest is a
trust which distributes shares to employees of the Barclays Group on the
exercise of options granted under the Barclays PLC 1991 SAYE Share Option
Scheme, the Barclays Group SAYE Share Option Scheme and the Woolwich plc
Sharesave Scheme (the 'Schemes')).
The trustee of the Quest also notified the Company on 2 April 2002 that it had
transferred 14,183 Barclays PLC ordinary shares on 2 April 2002 to participants
in the Schemes following the exercise of their options. Following this
transaction, each of the directors listed above ceased to have an interest in
such shares.
2. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust, (the 'trust') notified the Company on 3 April 2002 that it had between 26
March and 28 March 2002 exercised its discretion and released 106,197 ordinary
shares in Barclays PLC at prices ranging from 2129p to 2159p to participants in
the Executive Share Award Scheme ('ESAS'). The participants to whom shares were
released are not directors of Barclays PLC.
3. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the 'Trust') notified the Company on 3 April 2002 that it purchased
137,743 ordinary shares on 28 March 2002 at a price of 2159p per share. None of
the shares purchased were in respect of an award made to a director of Barclays
PLC.
4. The independent trustee of the Barclays Group (ESAS) Supplementary
Trust (the 'ESAS Supplementary trust') notified the Company on 3 April 2002 that
it had on 28 March 2002 purchased a total of 6,661 ordinary shares in Barclays
PLC at a price of 2159p per share. None of the shares purchased were in respect
of an award made to a director of Barclays PLC.
5. The independent trustee of the Barclays Group (PSP & ESOS) Trust (the '
PSP & ESOS trust') notified the Company on 3 April 2002 that it had on 28 March
2002 exercised its discretion and released 2,783 ordinary shares in Barclays PLC
to participants who exercised their awards under the Barclays Group Performance
Share Plan ('PSP'). The participant to whom shares were released is not a
director of Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 14,534,857 ordinary shares in Barclays PLC. Sir
Peter Middleton, Mr M W Barrett, Sir Andrew Large, Mr C J Lendrum, Mr J M
Stewart and Mr J S Varley, directors of Barclays PLC, are amongst the potential
beneficiaries under these trusts and are therefore regarded for Companies Act
purposes as being interested in the Barclays PLC ordinary shares held in them.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.